AI trial to tackle breast cancer launched

Nearly 700,000 women across the country will take part in a trial to test how AI tools can be used to catch breast cancer cases earlier, the DHSC has announced.

© National Cancer Institute/Unsplash

© National Cancer Institute/Unsplash

Under the plans, 30 testing sites across the country will be enhanced with the latest digital AI technologies, ready to invite women already booked in for routine screenings on the NHS to take part.

The technology will assist radiologists, screening patients to identify changes in breast tissue that show possible signs of cancer and referred for further investigations if required.

Currently two specialists are needed per mammogram screening, but this technology will enable just one to complete the same mammogram screening process safely and efficiently.

The EDITH trial is backed by £11m of government support via the National Institute for Health and Care Research (NIHR).

Prof Lucy Chappell, chief scientific adviser at the DHSC and chief executive of the NIHR, said: ‘This landmark trial could lead to a significant step forward in the early detection of breast cancer, offering women faster, more accurate diagnoses when it matters most. 

‘It is another example of how NIHR research, shaped and funded by the public, is crucial for rigorously testing world-leading new technologies, such as AI, that can potentially save lives while reducing the burden on the NHS.'

Waiting lists fall to 26-month low in May

Waiting lists fall to 26-month low in May

By Lee Peart 10 July 2025

NHS waiting lists fell by almost 30,000 in May to a 26-month low of 7.36m, NHSE has revealed.

High street pharmacies to offer 'sponge-on-a-string' cancer test

By Lee Peart 09 July 2025

High street pharmacies will offer a ‘sponge-on-a-string’ test as part of a new NHS pilot to help prevent oesophageal cancer.

Cancer trial could mean 1m fewer outpatient clinic appointments

By Lee Peart 08 July 2025

A cancel trial at The Shrewsbury and Telford Hospital NHS Trust (SaTH) could mean 1m fewer outpatient appointments.


Popular articles by Liz Wells